Dr. Tian Zhang discusses tivozanib for advanced kidney cancer

Video

Tian Zhang, MD, associate professor at UT Southwestern Medical Center, discusses the FDA-approved therapy tivozanib (Fotivda) for patients with relapsed or refractory advanced renal cell carcinoma, including ongoing trials further exploring the agent.

Related Videos
Nirmish Singla, MD, MSc, answers a question during a Zoom video interview
Human kidney cross section on scientific background | Image Credit: © Crystal light - stock.adobe.com
Nirmish Singla, MD, MSc, answers a question during a Zoom video interview
Carlos Muñoz-Lopez and Dr. Steven Campbell in an interview with Urology Times
Carlos Muñoz-Lopez and Dr. Steven Campbell in an interview with Urology Times
Dr. Michael Stifelman in an interview with Urology Times
Teona Iarajuli in an interview with Urology Times
hospital corridor
Related Content
© 2023 MJH Life Sciences

All rights reserved.